FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
This article was originally published in The Tan Sheet
Executive Summary
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology